Trader consensus on Polymarket heavily favors Anthropic remaining independent before 2027, with "No" at an 88.5% implied probability, driven by the company's explosive growth to a $30 billion annual revenue run-rate and its role as an active acquirer rather than acquisition target. Recent moves, including the $400 million stock purchase of stealth biotech startup Coefficient Bio on April 3 and the February acquisition of Vercept to bolster Claude's computer-use capabilities, underscore strategic autonomy amid Claude model expansions like Mythos and Microsoft Office integrations. Backed by multi-billion commitments from Amazon and Google for minority stakes and TPU capacity scaling to 5 gigawatts in 2027, Anthropic eyes an October IPO raising up to $60 billion. While economic pressures or intensified competition could shift dynamics, no credible buyout talks have emerged, reinforcing the strong market-implied odds.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$13,431 Vol.
$13,431 Vol.
$13,431 Vol.
$13,431 Vol.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Market Opened: Nov 12, 2025, 5:14 PM ET
Resolver
0x65070BE91...Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus on Polymarket heavily favors Anthropic remaining independent before 2027, with "No" at an 88.5% implied probability, driven by the company's explosive growth to a $30 billion annual revenue run-rate and its role as an active acquirer rather than acquisition target. Recent moves, including the $400 million stock purchase of stealth biotech startup Coefficient Bio on April 3 and the February acquisition of Vercept to bolster Claude's computer-use capabilities, underscore strategic autonomy amid Claude model expansions like Mythos and Microsoft Office integrations. Backed by multi-billion commitments from Amazon and Google for minority stakes and TPU capacity scaling to 5 gigawatts in 2027, Anthropic eyes an October IPO raising up to $60 billion. While economic pressures or intensified competition could shift dynamics, no credible buyout talks have emerged, reinforcing the strong market-implied odds.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions